Cures and curcumin: Turmeric offers potential therapy for oral cancers

April 24, 2015

Turmeric—the familiar yellow spice common in Indian and Asian cooking—may play a therapeutic role in oral cancers associated with human papillomavirus, according to new research published in ecancermedicalscience.

One of the herb's key active ingredients - an antioxidant called curcumin - appears to have a quelling effect on the activity of (HPV).

HPV is a virus that promotes the development of cervical and oral cancer. There is no cure, but curcumin may offer a means of future control.

"Turmeric has established antiviral and anti-cancer properties," says corresponding author Dr Alok Mishra of Emory University, Atlanta, USA. "And according to our new findings, we could say that it's good for oral health too."

Dr Mishra's research group first noted the effect of curcumin on HPV and cervical cancer cells in 2005. The antioxidant slowed the expression of HPV, suggesting that curcumin could control the extent of HPV infection.

"Since HPV-related oral cancer cases are on the rise, we tested the same hypothesis on oral cancer," Dr Mishra says.

"They turned out to be some very interesting findings."

The new research indicates that curcumin turns down the expression of HPV in infected cells by downregulating the levels of cellular transcription factors AP-1 and NF-kB.

These findings could suggest a new therapeutic role for cucurmin in cancer control.

While Dr Mishra cannot comment on the therapeutic benefits of turmeric in cooking, he says that the use of turmeric and other anti-oxidants may be good for health in general, and HPV-related oral cancers in particular.

Explore further: Study supports HPV vaccination guidelines

Related Stories

Study supports HPV vaccination guidelines

April 21, 2015
(HealthDay)—New research finds that young women who get the HPV vaccine gain significant protection against infection in three parts of the body if they haven't already been exposed to the human papillomavirus.

Oral cancer-causing HPV may spread through oral and genital routes

November 12, 2014
Oral human papillomavirus (HPV) infections were more common among men who had female partners with oral and/or genital HPV infection, suggesting that the transmission of HPV occurs via oral-oral and oral-genital routes, according ...

Oral HPV infection lasts longer in older men, study finds

January 9, 2015
(HealthDay)—One type of oral HPV (human papillomavirus) infection, HPV16, seems to last a year or longer in men over the age of 45 than it does in younger men, new research indicates.

Oral HPV infection, HPV-related cancers more common in men

January 26, 2012
Oral HPV infection is more common among men than women, explaining why men are more prone than women to develop an HPV related head and neck cancer, according to a study presented at the Multidisciplinary Head and Neck Cancer ...

HPV vaccination of adolescent boys may be cost-effective for preventing oropharyngeal cancer

April 13, 2015
A new study indicates that vaccinating 12-year-old boys against the humanpapilloma virus (HPV) may be a cost-effective strategy for preventing oropharyngeal squamous cell cancer, a cancer that starts at the back of the throat ...

Single men, smokers at higher risk for oral human papillomavirus infection, study shows

July 3, 2013
(Medical Xpress)—Smokers and single men are more likely to acquire cancer-causing oral human papillomavirus (HPV), according to new results from the HPV Infection in Men (HIM) Study. Researchers from Moffitt Cancer Center, ...

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.